openPR Logo
Press release

Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science

05-07-2021 05:30 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Organoids Market

Organoids Market

According to our new research study on “Organoids Market to 2027 – Global Analysis and Forecast – by Type, Application, and Source,” the organoids market was valued at US$ 689.47 million in 2019 and is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% during 2020–2027. The growth of the market is attributed to increasing demand for tumor modelling and biobanking, escalating adoption of personalized drugs, and growing focus on developing alternatives for animal testing models. However, issues related to the incorporation of organoids into existing workflows and dearth of skilled professionals hinder the growth of the market. `

Request Sample Copy of Organoids Market research report at –

Company Profiles

STEMCELL Technologies, Inc.
Cellesce Ltd.
Hubrecht Organoid Technology
3Dnamics, Inc.
Organoid Therapeutics
PeproTech, Inc.
Thermo Fisher Scientific
Corning Incorporated (Life Sciences)
Merck KGgA

In 2019, North America dominated the global organoids market. The market growth in the region is credited to the rise in the implementation of organoid-based research models in the biotechnology sector in US and Canada. These novel technologies have helped the researchers to overcome limitations faced by 2D cell culture platforms as 3D spheroids offer a microenvironment that can mimic the properties of human tissue structures. The market growth in Canada and Mexico is attributed to the presence of international market players, increasing adoption of advanced technologies, and existence of supportive government regulations. Based on type, the organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. The intestine segment accounted for more than 23.31% of the market in 2019. On the basis of application, the organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment is expected to held the largest share of the market in 2019 owing to its consideration as primary investigative research tool of the human developmental biology. Further, the pluripotent stem cells segment accounted for a larger share in the organoids market, by source, in 2019.

Increasing Use of Personalized Drugs Fuels Organoids Market Growth

Personalized medicine is a flourishing area of therapeutics that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be prescribed as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the past five years, and they are further likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies is providing exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express an interest in purchasing customized products or services. Since the release of the Precision Medicine Initiative in the US in 2015, pharmaceutical researchers have been pursuing the development of more tailored treatments for making medicines safer and more effective.

Personalized cancer therapy involves using personalized tumor models with similar characteristics to the original tumors, which may result in accurate predictions of drug responses in patients. One of the key advantages of tumor organoid models involve the conservation of molecular and cellular composition of the original tumor, which highlights the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Organoids Market: Segmental Overview

In terms of type, the kidney organoids segment is anticipated to register the highest CAGR in the organoids market during the forecast period. Kidney organoids, derived from human pluripotent stem cells, have the potential to assist the drug development process. An international team of researchers—led by Nanyang Technological University Singapore (NTU Singapore)—has grown “miniature kidneys” in laboratory, which could be used to better understand the mechanism of development of renal diseases in individual patients. The mini kidneys, i.e., kidney organoids, were grown in vitro from skin cells derived from a single patient who had polycystic kidney disease, one of the most common inherited causes of kidney failure in adults. In terms of application, the developmental biology disease segment accounted for more than 29% share in global organoids market in 2019. In terms of source, the market for the pluripotent stem cells segment is anticipated to grow at a higher CAGR during the forecast period.

Organoids Market: Competition Landscape and Key Developments

STEMCELL Technologies, Inc, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences) and Merck KGgA. are among the key companies operating in the global organoids market. Leading players are focusing on the expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.

In October 2019, Corning Incorporated launched two new products—Elplasia and Matrigel—to its organoid culture portfolio to provide new solutions to support spheroid and organoid culture models. Elplasia, a 3D cell culture microplate, features a microcavity technology that enables high-volume spheroid formation, culture, and analysis. The Matrigel matrix for organoid culture is optimized to support organoid growth and differentiation.

In Sep-2018, STEMCELL Technologies Signed a partnership agreement with Brigham and Women’s Hospital to commercialize a human pluripotent stem cell-derived kidney organoid culture system.

Market Segmentation

By Type


By Application

Developmental Biology
Disease Pathology of Infectious Disease
Regenerative Medicine
Drug Toxicity and Efficacy Testing
Drug Discovery and Personalized Medicine

By Source

Pluripotent Stem Cells
Organ-Specific Adult Stem Cells

By Geography

North America
Rest of Europe
Asia Pacific (APAC)
South Korea
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
Rest of Middle East & Africa
South America (SCAM)
Rest of South & Central America

Order a copy of this research Organoids Market research report at –

Contact US:
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science here

News-ID: 2281753 • Views: 893

More Releases from The Insight Partners

Friction Modifiers Market: Global Industry Perspective, Competitive Tracking, St …
Friction Modifiers Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. An exclusive Friction Modifiers market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation
Glass Fiber Reinforced Plastics Composites Market Research Insights, Size, Share …
Glass Fiber Reinforced Plastics Composites Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. An exclusive Glass Fiber Reinforced Plastics Composites market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific,
Resin Coffee Table Market New Innovations, Challenges, Opportunities, Strategies …
Resin Coffee Table Market research report by The Insight Partners includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2022 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the Resin Coffee Table market growth. Get
Project Management Software Market 2022 by Key Players, Development Status, Grow …
Project Management Software Market Research study 2022-2028 enhances the decision making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at The Insight Partners. The Project Management Software Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status Project management software automates task assignments, resource allocation, and tracking for all phases of a project.

All 5 Releases

More Releases for Organoid

Organoid Research Market Development Trends & Competitive Analysis by Leading In …
Global Organoids Market: An Overview The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation. Recent advancements in Big Data, and technologies like 3D printing have opened up new skies of growth for innovation. Organoids is a simplified and compact version of organs which depicts micro-anatomy realistically. These are usually made up of stem cells, tissues, or pluripotent stem cells. These can
Cancer Tumor Organoid Modifying the Overall Cancer Market Scenario
Within no time, the organoid cultures for cancer treatment have emerged as one of the most powerful modeling system in the field of cancer biology. From the very beginning of the market, it has been experiencing high adoption rate among the researchers and patients, minimum side effects and maximum appreciation for being unique among all the other 2-D model systems available in the market. The arrival of cancer organoids by
COVID-19 is Impacting the Organoid Kit Market | Key Players, Size, Trends, Oppor …
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Organoid Kit Market which would mention How the Covid-19 is Affecting the Organoid Kit Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Organoid Kit Players to Combat Covid-19 Impact. The Global Organoid Kit Market has been garnering remarkable momentum in the recent years.
Global Handmade Wallpaper Market 2019 - NLXL, Organoid Technologies GmbH, Paul M …
This new report by Eon Market Research, titled “Global Handmade Wallpaper Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Handmade Wallpaper industry at a global as well as regional and country level. Key facts analyzed in this report include the Handmade Wallpaper market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study
Global Energy-Efficient Decorative Panels Market 2017 - Organoid Technologies, W …
The Apex research study, titled Worldwide Energy-Efficient Decorative Panels Market 2016, presents critical information and factual data about the Energy-Efficient Decorative Panels market globally, providing an overall statistical study of the Energy-Efficient Decorative Panels market on the basis of market drivers, Energy-Efficient Decorative Panels Market limitations, and its future prospects. The prevalent global Energy-Efficient Decorative Panels trends and opportunities are also taken into consideration in Energy-Efficient Decorative Panels industry study. This
The HUB explores 3D organoid cultures for personalised modelling in drug discove …
Robert Vries, Managing Director at the Hubrecht Organoid Technology Foundation (The HUB) has joined the speaker lineup for SMi Group’s launch conference on 3D Cell Culture. The event will take place on the 22nd and 23rd of February 2017 in London. The HUB is a leading institution on organoid technology, and has established a ‘living biobank’. This growing collection of organoids from patients with various forms of cancer is used